跳转至内容
Merck
CN
  • CDC6 regulates both G2/M transition and metaphase-to-anaphase transition during the first meiosis of mouse oocytes.

CDC6 regulates both G2/M transition and metaphase-to-anaphase transition during the first meiosis of mouse oocytes.

Journal of cellular physiology (2020-01-28)
Zi-Yun Yi, Tie-Gang Meng, Xue-Shan Ma, Jian Li, Chun-Hui Zhang, Ying-Chun Ouyang, Heide Schatten, Jie Qiao, Qing-Yuan Sun, Wei-Ping Qian
摘要

Cell division cycle protein, CDC6, is essential for the initiation of DNA replication. CDC6 was recently shown to inhibit the microtubule-organizing activity of the centrosome. Here, we show that CDC6 is localized to the spindle from pro-metaphase I (MI) to MII stages of oocytes, and it plays important roles at two critical steps of oocyte meiotic maturation. CDC6 depletion facilitated the G2/M transition (germinal vesicle breakdown [GVBD]) through regulation of Cdh1 and cyclin B1 expression and CDK1 (CDC2) phosphorylation in a GVBD-inhibiting culture system containing milrinone. Furthermore, GVBD was significantly decreased after knockdown of cyclin B1 in CDC6-depleted oocytes, indicating that the effect of CDC6 loss on GVBD stimulation was mediated, at least in part, by raising cyclin B1. Knockdown of CDC6 also caused abnormal localization of γ-tubulin, resulting in defective spindles, misaligned chromosomes, cyclin B1 accumulation, and spindle assembly checkpoint (SAC) activation, leading to significant pro-MI/MI arrest and PB1 extrusion failure. These phenotypes were also confirmed by time-lapse live cell imaging analysis. The results indicate that CDC6 is indispensable for maintaining G2 arrest of meiosis and functions in G2/M checkpoint regulation in mouse oocytes. Moreover, CDC6 is also a key player regulating meiotic spindle assembly and metaphase-to-anaphase transition in meiotic oocytes.

材料
货号
品牌
产品描述

Sigma-Aldrich
抗γ-微管蛋白抗体,小鼠单克隆 小鼠抗, clone GTU-88, ascites fluid
Sigma-Aldrich
抗-α-微管蛋白−FITC抗体,小鼠单克隆抗体, clone DM1A, purified from hybridoma cell culture
Sigma-Aldrich
MISSION® esiRNA, targeting human CDC6